Login / Signup
PCSK9 is a promising prognostic marker in patients with advanced NSCLC.
Aldo Bonaventura
Francesco Grossi
Fabrizio Montecucco
Published in:
Cancer immunology, immunotherapy : CII (2020)
Keyphrases
</>
small cell lung cancer
advanced non small cell lung cancer
low density lipoprotein
brain metastases
epidermal growth factor receptor